The Cabinet on 14 October approved the sale of 60.72% of IDBI Bank to Canada's Fairfax Financial for a reported ₹52,878 crore — the largest foreign direct investment ever into India's financial sector. Against the 1,075.24 crore shares IDBI's quarterly filings show outstanding, that is roughly ₹81 a share. Every version of the story framed it identically: a foreign insurer betting big on Indian banking.

Here is what none of them mentioned. Fairfax is already the promoter or promoter-group of five NSE-listed companies, with a sixth transaction in progress. One of those five is a bank — and it filed its annual report eight days before the Cabinet met.

CSB Bank: the 40% that only votes 26%

CSB Bank (CSBBANK) published its FY2025-26 annual report on 6 October 2026. Under the heading "Promoter Holding – FIH Mauritius Investments Ltd," it states that FIHM "holds 40% of the paid-up capital of the Bank" — 6,93,94,331 shares as on 31 March 2026 — then adds the sentence that matters: "FIHM holding in the Bank is subject to the dilution schedule as mandated by Reserve Bank of India."

The same report goes further. Under Section 12(2) of the Banking Regulation Act, 1949 and the RBI (Commercial Banks – Acquisition and Holding of Shares or Voting Rights) Directions, 2025, "the voting rights of FIHM in the Bank is presently capped at 26% of the total voting rights of the Bank."

So Fairfax owns 40% of CSB's economics and can vote 26% of it. This is not theoretical. The previous year's annual report records the first tranche in plain language: "FIHM, on June 27, 2024, as part of the dilution schedule, sold 16,868,645 shares, which constitute 9.72% of the paid-up capital of the Bank, and accordingly, their holdings were brought down to the current level of 40.00%... from 49.72%."

That is a promoter already compelled to sell once, capped on votes, and stating in writing that more dilution is scheduled. RBI's framework does not contemplate one promoter group controlling two commercial banks. The market is reading IDBI as CSB acquiring a richer parent. CSB's filings describe a parent under instruction to shrink.

What is being shrunk is not a troubled bank. Per the FY26 report: net profit ₹633 crore (up 6.6%) on total income of ₹5,682 crore, net advances ₹39,848 crore (up 26.7%), deposits ₹44,246 crore (up 20%), capital adequacy 20.66%, gross NPA 1.66%.

One more detail. On 25 September 2026 — less than three weeks before the Cabinet decision — CSB's board appointed Anish Thurthi as a non-executive director "nominated by FIH Mauritius Investments Ltd, the promoter of the Bank." Quess Corp's filings describe Thurthi as a Director of Fairbridge Capital Private Limited, Fairfax's India investment arm. Fairfax refreshed its seat at CSB's table immediately before it won a second bank.

Where Fairfax is actually buying: IIFL Capital

For Fairfax's revealed preference, read IIFL Capital Services' (IIFLCAPS) FY2026 annual report, filed 17 August 2026. Fairfax has "proposed to increase its shareholding in the Company to at least 51% through a combination of transactions, including a preferential issue of equity shares aggregating ~₹2,000 Crores at an issue price of ₹350 per equity share, an open offer, and arrangements with the existing Promoters." Shareholders approved that issue at an EGM on 1 June 2026, and on completion Fairfax "will become part of the Promoter Group... and will have the right to nominate two directors on the Board."

The price is the tell. That same report records IIFL Capital's market capitalisation at 31 March 2026 as ₹7,604 crore across 31,14,34,713 shares — about ₹244 a share. Fairfax agreed to pay ₹350, roughly 43% above that, for a business that earned ₹564 crore of profit after tax on ₹2,603 crore of revenue in FY26. At ₹350, ₹2,000 crore buys about 5.7 crore new shares — some 18% of the count outstanding. Fairfax is paying up to add one financial-services asset while a mandated schedule pushes it out of another.

The rest of the book

Thomas Cook's FY26 report ties the whole book to one desk: Fairbridge's managing director Sumit Maheshwari "has been closely involved in the investments of Bangalore Airport, Sanmar Group, CSB Bank, Fairchem Organics, Seven Islands Shipping, Thomas Cook, Quess Corp, Sterling Holiday amongst others."

What retail investors should do

Do not buy CSBBANK on the theory that a deeper-pocketed promoter is arriving. The filings point the other way: a vote-capped promoter on a disclosed RBI dilution schedule that has already executed one 9.72% tranche, in a bank whose promoter almost certainly cannot stay at 40% while Fairfax owns 60.72% of IDBI. Outcomes range from an open-market sell-down that caps the stock for quarters, to a negotiated block, to a merger — only the last is clearly good for minorities. Watch two disclosures: any Regulation 29/31 shareholding change filed by FIHM, and any amendment to the Amended and Restated Investment Agreement dated 15 October 2018 (and its 2020 addendum) that CSB's FY26 report confirms still binds the bank to its promoter.

IIFLCAPS holders face the opposite asymmetry: the ₹350 price and a mandatory open offer are already on record, so the question is roughly 18% dilution against a parent committing to 51%. And treat "Fairfax is bullish on India" as too blunt to trade on. Across its portfolio companies' filings, Fairfax has been diluting at Thomas Cook, is scheduled to dilute at CSB, has held Quess and Bluspring flat, and is paying up for control at exactly one listed name.

Data sourced from company filings on NSE via Xaro.